ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Coagulation Factor VIII Market Research Report 2025
Published Date: 2025-06-03
|
Report Code: QYRE-Auto-28G16009
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human Coagulation Factor VIII Market Research Report 2023
BUY CHAPTERS

Global Recombinant Human Coagulation Factor VIII Market Research Report 2025

Code: QYRE-Auto-28G16009
Report
2025-06-03
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Baxter
Bayer
Pfizer Inc
Novo Nordisk A S

Recombinant Human Coagulation Factor VIII Market

The global market for Recombinant Human Coagulation Factor VIII was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Recombinant human coagulation factor VIII is used for the treatment of hemophilia A due to plasma coagulation factor VIII (FVIII) deficiency. Temporarily replaces missing clotting factors during correction or prevention of bleeding, emergency or elective surgery.
North American market for Recombinant Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Recombinant Human Coagulation Factor VIII include Baxter, Bayer, Pfizer, Green Cross Corporation, Novo Nordisk A/S, SinoCellTech, Takeda Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Coagulation Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Coagulation Factor VIII.
The Recombinant Human Coagulation Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Coagulation Factor VIII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Coagulation Factor VIII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Human Coagulation Factor VIII Market Report

Report Metric Details
Report Name Recombinant Human Coagulation Factor VIII Market
Segment by Type
  • 250 IU/bottle
  • 500 IU/bottle
  • 1000IU/bottle
  • Others
Segment by Application
  • Hemophilia A
  • Spontaneous Trauma
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter, Bayer, Pfizer, Green Cross Corporation, Novo Nordisk A/S, SinoCellTech, Takeda Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Human Coagulation Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Human Coagulation Factor VIII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Recombinant Human Coagulation Factor VIII Market report?

Ans: The main players in the Recombinant Human Coagulation Factor VIII Market are Baxter, Bayer, Pfizer, Green Cross Corporation, Novo Nordisk A/S, SinoCellTech, Takeda Pharmaceuticals

What are the Application segmentation covered in the Recombinant Human Coagulation Factor VIII Market report?

Ans: The Applications covered in the Recombinant Human Coagulation Factor VIII Market report are Hemophilia A, Spontaneous Trauma, Others

What are the Type segmentation covered in the Recombinant Human Coagulation Factor VIII Market report?

Ans: The Types covered in the Recombinant Human Coagulation Factor VIII Market report are 250 IU/bottle, 500 IU/bottle, 1000IU/bottle, Others

1 Recombinant Human Coagulation Factor VIII Market Overview
1.1 Product Definition
1.2 Recombinant Human Coagulation Factor VIII by Type
1.2.1 Global Recombinant Human Coagulation Factor VIII Market Value Comparison by Type (2024 VS 2031)
1.2.2 250 IU/bottle
1.2.3 500 IU/bottle
1.2.4 1000IU/bottle
1.2.5 Others
1.3 Recombinant Human Coagulation Factor VIII by Application
1.3.1 Global Recombinant Human Coagulation Factor VIII Market Value by Application (2024 VS 2031)
1.3.2 Hemophilia A
1.3.3 Spontaneous Trauma
1.3.4 Others
1.4 Global Recombinant Human Coagulation Factor VIII Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Coagulation Factor VIII Revenue 2020-2031
1.4.2 Global Recombinant Human Coagulation Factor VIII Sales 2020-2031
1.4.3 Global Recombinant Human Coagulation Factor VIII Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Human Coagulation Factor VIII Market Competition by Manufacturers
2.1 Global Recombinant Human Coagulation Factor VIII Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Human Coagulation Factor VIII Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Human Coagulation Factor VIII Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Human Coagulation Factor VIII, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Coagulation Factor VIII, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Human Coagulation Factor VIII, Date of Enter into This Industry
2.8 Global Recombinant Human Coagulation Factor VIII Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Coagulation Factor VIII Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Human Coagulation Factor VIII Players Market Share by Revenue
2.8.3 Global Recombinant Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Coagulation Factor VIII Market Scenario by Region
3.1 Global Recombinant Human Coagulation Factor VIII Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Human Coagulation Factor VIII Sales by Region: 2020-2031
3.2.1 Global Recombinant Human Coagulation Factor VIII Sales by Region: 2020-2025
3.2.2 Global Recombinant Human Coagulation Factor VIII Sales by Region: 2026-2031
3.3 Global Recombinant Human Coagulation Factor VIII Revenue by Region: 2020-2031
3.3.1 Global Recombinant Human Coagulation Factor VIII Revenue by Region: 2020-2025
3.3.2 Global Recombinant Human Coagulation Factor VIII Revenue by Region: 2026-2031
3.4 North America Recombinant Human Coagulation Factor VIII Market Facts & Figures by Country
3.4.1 North America Recombinant Human Coagulation Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Human Coagulation Factor VIII Sales by Country (2020-2031)
3.4.3 North America Recombinant Human Coagulation Factor VIII Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Coagulation Factor VIII Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Coagulation Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Human Coagulation Factor VIII Sales by Country (2020-2031)
3.5.3 Europe Recombinant Human Coagulation Factor VIII Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Coagulation Factor VIII Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Coagulation Factor VIII Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Human Coagulation Factor VIII Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Human Coagulation Factor VIII Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Coagulation Factor VIII Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Coagulation Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Human Coagulation Factor VIII Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Human Coagulation Factor VIII Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Human Coagulation Factor VIII Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Coagulation Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Human Coagulation Factor VIII Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Human Coagulation Factor VIII Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Coagulation Factor VIII Sales by Type (2020-2031)
4.1.1 Global Recombinant Human Coagulation Factor VIII Sales by Type (2020-2025)
4.1.2 Global Recombinant Human Coagulation Factor VIII Sales by Type (2026-2031)
4.1.3 Global Recombinant Human Coagulation Factor VIII Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Human Coagulation Factor VIII Revenue by Type (2020-2031)
4.2.1 Global Recombinant Human Coagulation Factor VIII Revenue by Type (2020-2025)
4.2.2 Global Recombinant Human Coagulation Factor VIII Revenue by Type (2026-2031)
4.2.3 Global Recombinant Human Coagulation Factor VIII Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Human Coagulation Factor VIII Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Human Coagulation Factor VIII Sales by Application (2020-2031)
5.1.1 Global Recombinant Human Coagulation Factor VIII Sales by Application (2020-2025)
5.1.2 Global Recombinant Human Coagulation Factor VIII Sales by Application (2026-2031)
5.1.3 Global Recombinant Human Coagulation Factor VIII Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Human Coagulation Factor VIII Revenue by Application (2020-2031)
5.2.1 Global Recombinant Human Coagulation Factor VIII Revenue by Application (2020-2025)
5.2.2 Global Recombinant Human Coagulation Factor VIII Revenue by Application (2026-2031)
5.2.3 Global Recombinant Human Coagulation Factor VIII Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Human Coagulation Factor VIII Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Recombinant Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Recombinant Human Coagulation Factor VIII Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Recombinant Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Recombinant Human Coagulation Factor VIII Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Recombinant Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Recombinant Human Coagulation Factor VIII Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Green Cross Corporation
6.4.1 Green Cross Corporation Company Information
6.4.2 Green Cross Corporation Description and Business Overview
6.4.3 Green Cross Corporation Recombinant Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Green Cross Corporation Recombinant Human Coagulation Factor VIII Product Portfolio
6.4.5 Green Cross Corporation Recent Developments/Updates
6.5 Novo Nordisk A/S
6.5.1 Novo Nordisk A/S Company Information
6.5.2 Novo Nordisk A/S Description and Business Overview
6.5.3 Novo Nordisk A/S Recombinant Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novo Nordisk A/S Recombinant Human Coagulation Factor VIII Product Portfolio
6.5.5 Novo Nordisk A/S Recent Developments/Updates
6.6 SinoCellTech
6.6.1 SinoCellTech Company Information
6.6.2 SinoCellTech Description and Business Overview
6.6.3 SinoCellTech Recombinant Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.6.4 SinoCellTech Recombinant Human Coagulation Factor VIII Product Portfolio
6.6.5 SinoCellTech Recent Developments/Updates
6.7 Takeda Pharmaceuticals
6.7.1 Takeda Pharmaceuticals Company Information
6.7.2 Takeda Pharmaceuticals Description and Business Overview
6.7.3 Takeda Pharmaceuticals Recombinant Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Takeda Pharmaceuticals Recombinant Human Coagulation Factor VIII Product Portfolio
6.7.5 Takeda Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Coagulation Factor VIII Industry Chain Analysis
7.2 Recombinant Human Coagulation Factor VIII Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Coagulation Factor VIII Production Mode & Process Analysis
7.4 Recombinant Human Coagulation Factor VIII Sales and Marketing
7.4.1 Recombinant Human Coagulation Factor VIII Sales Channels
7.4.2 Recombinant Human Coagulation Factor VIII Distributors
7.5 Recombinant Human Coagulation Factor VIII Customer Analysis
8 Recombinant Human Coagulation Factor VIII Market Dynamics
8.1 Recombinant Human Coagulation Factor VIII Industry Trends
8.2 Recombinant Human Coagulation Factor VIII Market Drivers
8.3 Recombinant Human Coagulation Factor VIII Market Challenges
8.4 Recombinant Human Coagulation Factor VIII Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Baxter
Bayer
Pfizer Inc
Novo Nordisk A S
List of Tables
 Table 1. Global Recombinant Human Coagulation Factor VIII Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Human Coagulation Factor VIII Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Human Coagulation Factor VIII Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Human Coagulation Factor VIII Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Human Coagulation Factor VIII Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Human Coagulation Factor VIII Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Human Coagulation Factor VIII Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Human Coagulation Factor VIII Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Human Coagulation Factor VIII, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Human Coagulation Factor VIII, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Human Coagulation Factor VIII, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Coagulation Factor VIII as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Human Coagulation Factor VIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Human Coagulation Factor VIII Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Human Coagulation Factor VIII Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Human Coagulation Factor VIII Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Human Coagulation Factor VIII Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Human Coagulation Factor VIII Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Human Coagulation Factor VIII Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Human Coagulation Factor VIII Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Human Coagulation Factor VIII Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Human Coagulation Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Human Coagulation Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Human Coagulation Factor VIII Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Human Coagulation Factor VIII Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Human Coagulation Factor VIII Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Human Coagulation Factor VIII Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Human Coagulation Factor VIII Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Human Coagulation Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Human Coagulation Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Human Coagulation Factor VIII Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Human Coagulation Factor VIII Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Human Coagulation Factor VIII Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Human Coagulation Factor VIII Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Human Coagulation Factor VIII Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Human Coagulation Factor VIII Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Human Coagulation Factor VIII Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Human Coagulation Factor VIII Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Human Coagulation Factor VIII Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Human Coagulation Factor VIII Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Human Coagulation Factor VIII Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Human Coagulation Factor VIII Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Human Coagulation Factor VIII Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Human Coagulation Factor VIII Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Human Coagulation Factor VIII Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Human Coagulation Factor VIII Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Human Coagulation Factor VIII Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Human Coagulation Factor VIII Price (US$/Unit) by Application (2026-2031)
 Table 70. Baxter Company Information
 Table 71. Baxter Description and Business Overview
 Table 72. Baxter Recombinant Human Coagulation Factor VIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Baxter Recombinant Human Coagulation Factor VIII Product
 Table 74. Baxter Recent Developments/Updates
 Table 75. Bayer Company Information
 Table 76. Bayer Description and Business Overview
 Table 77. Bayer Recombinant Human Coagulation Factor VIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bayer Recombinant Human Coagulation Factor VIII Product
 Table 79. Bayer Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Recombinant Human Coagulation Factor VIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Recombinant Human Coagulation Factor VIII Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Green Cross Corporation Company Information
 Table 86. Green Cross Corporation Description and Business Overview
 Table 87. Green Cross Corporation Recombinant Human Coagulation Factor VIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Green Cross Corporation Recombinant Human Coagulation Factor VIII Product
 Table 89. Green Cross Corporation Recent Developments/Updates
 Table 90. Novo Nordisk A/S Company Information
 Table 91. Novo Nordisk A/S Description and Business Overview
 Table 92. Novo Nordisk A/S Recombinant Human Coagulation Factor VIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Novo Nordisk A/S Recombinant Human Coagulation Factor VIII Product
 Table 94. Novo Nordisk A/S Recent Developments/Updates
 Table 95. SinoCellTech Company Information
 Table 96. SinoCellTech Description and Business Overview
 Table 97. SinoCellTech Recombinant Human Coagulation Factor VIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. SinoCellTech Recombinant Human Coagulation Factor VIII Product
 Table 99. SinoCellTech Recent Developments/Updates
 Table 100. Takeda Pharmaceuticals Company Information
 Table 101. Takeda Pharmaceuticals Description and Business Overview
 Table 102. Takeda Pharmaceuticals Recombinant Human Coagulation Factor VIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Takeda Pharmaceuticals Recombinant Human Coagulation Factor VIII Product
 Table 104. Takeda Pharmaceuticals Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Recombinant Human Coagulation Factor VIII Distributors List
 Table 108. Recombinant Human Coagulation Factor VIII Customers List
 Table 109. Recombinant Human Coagulation Factor VIII Market Trends
 Table 110. Recombinant Human Coagulation Factor VIII Market Drivers
 Table 111. Recombinant Human Coagulation Factor VIII Market Challenges
 Table 112. Recombinant Human Coagulation Factor VIII Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Human Coagulation Factor VIII
 Figure 2. Global Recombinant Human Coagulation Factor VIII Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Human Coagulation Factor VIII Market Share by Type: 2024 & 2031
 Figure 4. 250 IU/bottle Product Picture
 Figure 5. 500 IU/bottle Product Picture
 Figure 6. 1000IU/bottle Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Recombinant Human Coagulation Factor VIII Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Recombinant Human Coagulation Factor VIII Market Share by Application: 2024 & 2031
 Figure 10. Hemophilia A
 Figure 11. Spontaneous Trauma
 Figure 12. Others
 Figure 13. Global Recombinant Human Coagulation Factor VIII Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Recombinant Human Coagulation Factor VIII Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Recombinant Human Coagulation Factor VIII Sales (2020-2031) & (K Units)
 Figure 16. Global Recombinant Human Coagulation Factor VIII Average Price (US$/Unit) & (2020-2031)
 Figure 17. Recombinant Human Coagulation Factor VIII Report Years Considered
 Figure 18. Recombinant Human Coagulation Factor VIII Sales Share by Manufacturers in 2024
 Figure 19. Global Recombinant Human Coagulation Factor VIII Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Recombinant Human Coagulation Factor VIII Players: Market Share by Revenue in Recombinant Human Coagulation Factor VIII in 2024
 Figure 21. Recombinant Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Recombinant Human Coagulation Factor VIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Recombinant Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
 Figure 24. North America Recombinant Human Coagulation Factor VIII Revenue Market Share by Country (2020-2031)
 Figure 25. United States Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Recombinant Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
 Figure 28. Europe Recombinant Human Coagulation Factor VIII Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Recombinant Human Coagulation Factor VIII Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Recombinant Human Coagulation Factor VIII Revenue Market Share by Region (2020-2031)
 Figure 36. China Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Recombinant Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Recombinant Human Coagulation Factor VIII Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Recombinant Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Recombinant Human Coagulation Factor VIII Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Recombinant Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Recombinant Human Coagulation Factor VIII by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Recombinant Human Coagulation Factor VIII by Type (2020-2031)
 Figure 55. Global Recombinant Human Coagulation Factor VIII Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Recombinant Human Coagulation Factor VIII by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Recombinant Human Coagulation Factor VIII by Application (2020-2031)
 Figure 58. Global Recombinant Human Coagulation Factor VIII Price (US$/Unit) by Application (2020-2031)
 Figure 59. Recombinant Human Coagulation Factor VIII Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions